ciprofloxacin has been researched along with Communicable Diseases, Emerging in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapadula, G | 1 |
| Viganò, F | 1 |
| Fortuna, P | 1 |
| Dolara, A | 1 |
| Bramati, S | 1 |
| Soria, A | 1 |
| Foresti, S | 1 |
| Gori, A | 1 |
| Tamang, MD | 1 |
| Nam, HM | 1 |
| Kim, TS | 1 |
| Jang, GC | 1 |
| Jung, SC | 1 |
| Lim, SK | 1 |
| Hall, RL | 1 |
| Partridge, R | 1 |
| Venkatraman, N | 1 |
| Wiselka, M | 1 |
| Branger, C | 1 |
| Zamfir, O | 1 |
| Geoffroy, S | 1 |
| Laurans, G | 1 |
| Arlet, G | 1 |
| Thien, HV | 1 |
| Gouriou, S | 1 |
| Picard, B | 1 |
| Denamur, E | 1 |
4 other studies available for ciprofloxacin and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Imported ciprofloxacin-resistant Neisseria meningitidis.
Topics: Adult; Ciprofloxacin; Communicable Diseases, Emerging; Contact Tracing; Drug Resistance, Bacterial; | 2009 |
Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.
Topics: Animals; Animals, Domestic; beta-Lactamases; Ciprofloxacin; Communicable Diseases, Emerging; DNA Tra | 2011 |
Invasive non-typhoidal salmonella infection with multifocal seeding in an immunocompetent host: an emerging disease in the developed world.
Topics: Abscess; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Communicable Diseases, Emerging; Diagnos | 2013 |
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Communicable Diseases, Emerging; Drug Resista | 2005 |